Avalo Therapeutics

+$0.02 (+0.91%) Today
+$0.09 (+4.05%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.

About AVTX

Avalo Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of treatments for rare and orphan diseases. Its lead product candidates include CERC-801, CERC-802, and CERC-803, which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation.

CEO
Michael F. Cola
Employees
32
Headquarters
Rockville, Maryland
Founded
2011

AVTX Key Statistics

Market Cap
240.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
287.64K
High Today
$2.27
Low Today
$2.11
Open Price
$2.18
Volume
380.15K
52 Week High
$4.50
52 Week Low
$1.98

AVTX Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure